China National Accord Medicines Corporation Ltd. (SHE: 000028)

China National Accord Medicines Corporation Revenue

China National Accord Medicines Corporation had revenue of 18.70B CNY in the quarter ending June 30, 2024, a decrease of -5.10%. This brings the company's revenue in the last twelve months to 74.88B, down -1.09% year-over-year. In the year 2023, China National Accord Medicines Corporation had annual revenue of 75.48B with 2.77% growth.

• Revenue (ttm): 74.88B
• Revenue Growth: -1.09%
• P/S Ratio: 0.19
• Revenue / Employee: 1.90M
• Employees: 39,449
• Market Cap: 13.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	75.48B	2.03B	2.77%
Dec 31, 2022	73.44B	5.09B	7.44%
Dec 31, 2021	68.36B	8.71B	14.60%
Dec 31, 2020	59.65B	6.86B	13.00%
Dec 31, 2019	52.79B	9.66B	22.41%